Daclatasvir Nitroso
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Daclatasvir is used along with another medication (sofosbuvir [Solvadi]) to treat a certain type of chronic hepatitis C (an ongoing viral infection that damages the liver). Daclatasvir is in a class of antiviral medications called hepatitis C virus (HCV) NS5A inhibitors.Daclatasvir Nitroso is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
Daclatasvir Nitroso CAS NO:NA chemically represented as Methyl ((S)-1-((S)-2-(5-(4'-(2-((S)-1-((methoxycarbonyl)-L-valyl)pyrrolidin-2-yl)-1H-imidazol-5-yl)-[1,1'-biphenyl]-4-yl)-1-nitroso-1H-imidazol-2-yl)pyrrolidin-1-yl)-3-methyl-1-oxobutan-2-yl)carbamate. Synchemia is the leading manufacturing and exporter of Daclatasvir Nitroso . We supply Daclatasvir Nitroso with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0143124 |
| CAS No | NA |
| Mol.F. | C28H24N4O6 |
| Mol.Wt. | 512.52 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143125 |
| CAS No | NA |
| Mol.F. | C36H29N5O9 |
| Mol.Wt. | 675.65 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143126 |
| CAS No | NA |
| Mol.F. | C17H14FN3O4 |
| Mol.Wt. | 343.31g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143127 |
| CAS No | NA |
| Mol.F. | C23H21N3O7 |
| Mol.Wt. | 451.44 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143128 |
| CAS No | NA |
| Mol.F. | C28H23FN4O7 |
| Mol.Wt. | 546.31 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143129 |
| CAS No | NA |
| Mol.F. | C28H23ClN4O6 |
| Mol.Wt. | 520.93 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143130 |
| CAS No | NA |
| Mol.F. | C22H26N2O5 |
| Mol.Wt. | 398.46 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143131 |
| CAS No | NA |
| Mol.F. | C22H25FN2O5 |
| Mol.Wt. | 416.45 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143132 |
| CAS No | NA |
| Mol.F. | C22H24F2N2O5 |
| Mol.Wt. | 434.44 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143133 |
| CAS No | NA |
| Mol.F. | C7H12N2O4 |
| Mol.Wt. | 188.18 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143134 |
| CAS No | NA |
| Mol.F. | C29H52N2O6 |
| Mol.Wt. | 524.74 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143135 |
| CAS No | NA |
| Mol.F. | C37H63N3O6 |
| Mol.Wt. | 645.93 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143136 |
| CAS No | NA |
| Mol.F. | C8H15N3O5 |
| Mol.Wt. | 233.22 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0143137 |
| CAS No | NA |
| Mol.F. | C16H17ClN2O2 |
| Mol.Wt. | 304.77 g/mole |
| INV STATUS | In Stock |
| CAT No | SRC-N0143138 |
| CAS No | NA |
| Mol.F. | C17H17N5O2S |
| Mol.Wt. | 355.42 g/mole |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0143139 |
| CAS No | NA |
| Mol.F. | C12H10N4OS |
| Mol.Wt. | 258.30 g/mole |
| INV STATUS | CUSTOM SYNTHESIS |